151 related articles for article (PubMed ID: 37079088)
1. [Re-irradiation and Bevacizumab - active combination for treatment of recurrent glioblastoma].
Seidel C; Nicolay NH
Strahlenther Onkol; 2023 Jun; 199(6):604-606. PubMed ID: 37079088
[No Abstract] [Full Text] [Related]
2. Outcomes of salvage fractionated re-irradiation combined with bevacizumab for recurrent high-grade gliomas that progressed after bevacizumab treatment*.
Yonezawa H; Ohno M; Igaki H; Miyakita Y; Takahashi M; Tamura Y; Shima S; Matsushita Y; Ichimura K; Narita Y
Jpn J Clin Oncol; 2021 Jul; 51(7):1028-1035. PubMed ID: 33959771
[TBL] [Abstract][Full Text] [Related]
3. Re-irradiation strategies in combination with bevacizumab for recurrent malignant glioma.
Schnell O; Thorsteinsdottir J; Fleischmann DF; Lenski M; Abenhardt W; Giese A; Tonn JC; Belka C; Kreth FW; Niyazi M
J Neurooncol; 2016 Dec; 130(3):591-599. PubMed ID: 27599828
[TBL] [Abstract][Full Text] [Related]
4. A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas.
Dixit KS; Sachdev S; Amidei C; Kumthekar P; Kruser TJ; Gondi V; Grimm S; Lukas RV; Nicholas MK; Chmura SJ; Fought AJ; Mehta M; Raizer JJ
J Neurooncol; 2021 Dec; 155(3):297-306. PubMed ID: 34689306
[TBL] [Abstract][Full Text] [Related]
5. Re-irradiation combined with bevacizumab for recurrent glioblastoma beyond bevacizumab failure: survival outcomes and prognostic factors.
You WC; Lee HD; Pan HC; Chen HC
Sci Rep; 2023 Jun; 13(1):9442. PubMed ID: 37296207
[TBL] [Abstract][Full Text] [Related]
6. Re-irradiation for recurrent glioblastoma multiforme.
Barney C; Shukla G; Bhamidipati D; Palmer JD
Chin Clin Oncol; 2017 Aug; 6(4):36. PubMed ID: 28841798
[TBL] [Abstract][Full Text] [Related]
7. Boron neutron capture therapy and add-on bevacizumab in patients with recurrent malignant glioma.
Furuse M; Kawabata S; Wanibuchi M; Shiba H; Takeuchi K; Kondo N; Tanaka H; Sakurai Y; Suzuki M; Ono K; Miyatake SI
Jpn J Clin Oncol; 2022 May; 52(5):433-440. PubMed ID: 35079791
[TBL] [Abstract][Full Text] [Related]
8. Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone.
Arvold ND; Shi DD; Aizer AA; Norden AD; Reardon DA; Lee EQ; Nayak L; Dunn IF; Golby AJ; Johnson MD; Claus EB; Chiocca EA; Ligon KL; Wen PY; Alexander BM
J Neurooncol; 2017 Dec; 135(3):581-591. PubMed ID: 28975467
[TBL] [Abstract][Full Text] [Related]
9. Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma.
Clarke J; Neil E; Terziev R; Gutin P; Barani I; Kaley T; Lassman AB; Chan TA; Yamada J; DeAngelis L; Ballangrud A; Young R; Panageas KS; Beal K; Omuro A
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):797-804. PubMed ID: 28870792
[TBL] [Abstract][Full Text] [Related]
10. Pulsed Reduced Dose Rate Radiotherapy in Conjunction With Bevacizumab or Bevacizumab Alone in Recurrent High-grade Glioma: Survival Outcomes.
Bovi JA; Prah MA; Retzlaff AA; Schmainda KM; Connelly JM; Rand SD; Marszalkowski CS; Mueller WM; Siker ML; Schultz CJ
Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):979-986. PubMed ID: 32599030
[TBL] [Abstract][Full Text] [Related]
11. Cs-131 brachytherapy for patients with recurrent glioblastoma combined with bevacizumab avoids radiation necrosis while maintaining local control.
Wernicke AG; Taube S; Smith AW; Herskovic A; Parashar B; Schwartz TH
Brachytherapy; 2020; 19(5):705-712. PubMed ID: 32928486
[TBL] [Abstract][Full Text] [Related]
12. Bevacizumab and re-irradiation for recurrent high grade gliomas: does sequence matter?
Palmer JD; Bhamidipati D; Song A; Eldredge-Hindy HB; Siglin J; Dan TD; Champ CE; Zhang I; Bar-Ad V; Kim L; Glass J; Evans JJ; Andrews DW; Werner-Wasik M; Shi W
J Neurooncol; 2018 Dec; 140(3):623-628. PubMed ID: 30182159
[TBL] [Abstract][Full Text] [Related]
13. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.
Shi W; Blomain ES; Siglin J; Palmer JD; Dan T; Wang Y; Werner-Wasik M; Glass J; Kim L; Bar Ad V; Bhamidipati D; Evans JJ; Judy K; Farrell CJ; Andrews DW
J Neurooncol; 2018 Mar; 137(1):171-177. PubMed ID: 29235052
[TBL] [Abstract][Full Text] [Related]
14.
Fleischmann DF; Unterrainer M; Bartenstein P; Belka C; Albert NL; Niyazi M
J Neurooncol; 2017 Apr; 132(2):277-286. PubMed ID: 28102485
[TBL] [Abstract][Full Text] [Related]
15. Amino-acid PET versus MRI guided re-irradiation in patients with recurrent glioblastoma multiforme (GLIAA) - protocol of a randomized phase II trial (NOA 10/ARO 2013-1).
Oehlke O; Mix M; Graf E; Schimek-Jasch T; Nestle U; Götz I; Schneider-Fuchs S; Weyerbrock A; Mader I; Baumert BG; Short SC; Meyer PT; Weber WA; Grosu AL
BMC Cancer; 2016 Oct; 16(1):769. PubMed ID: 27716184
[TBL] [Abstract][Full Text] [Related]
16. Re-irradiation for recurrent glioblastoma multiforme: a critical comparison of different concepts.
Baehr A; Trog D; Oertel M; Welsch S; Kröger K; Grauer O; Haverkamp U; Eich HT
Strahlenther Onkol; 2020 May; 196(5):457-464. PubMed ID: 32016497
[TBL] [Abstract][Full Text] [Related]
17. Re-irradiation in the Brain: Primary Gliomas.
Ho ALK; Jena R
Clin Oncol (R Coll Radiol); 2018 Feb; 30(2):124-136. PubMed ID: 29295736
[TBL] [Abstract][Full Text] [Related]
18. The evolving role for re-irradiation in the management of recurrent grade 4 glioma.
Howard SP; Krauze A; Chan MD; Tsien C; Tomé WA
J Neurooncol; 2017 Sep; 134(3):523-530. PubMed ID: 28386661
[TBL] [Abstract][Full Text] [Related]
19. Re-irradiation as salvage treatment in recurrent glioblastoma: A comprehensive literature review to provide practical answers to frequently asked questions.
Scoccianti S; Francolini G; Carta GA; Greto D; Detti B; Simontacchi G; Visani L; Baki M; Poggesi L; Bonomo P; Mangoni M; Desideri I; Pallotta S; Livi L
Crit Rev Oncol Hematol; 2018 Jun; 126():80-91. PubMed ID: 29759570
[TBL] [Abstract][Full Text] [Related]
20. Patterns of relapse in patients with high grade glioma receiving combined treatments including stereotactic re-irradiation for a first relapse.
Antoni D; Jastaniah Z; Haoming QC; Gaultier C; Ahle G; Couchot J; Atlani D; Schott R; Clavier JB; Srour R; Chaussemy D; Noël G
Cancer Radiother; 2016 Jun; 20(4):282-91. PubMed ID: 27318555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
